[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002994:Clofibrate / Q000494:pharmacology; D003911:Dextrans / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy; D013442:Sulfinpyrazone / Q000494:pharmacology; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*
D003911:Dextrans; D004176:Dipyridamole; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone
Tromboseprofylakse med trombocytfunktionshaemmere. 2. Kliniske resultater.